Cell Genomics (Jan 2023)

Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma

  • Kyung Duk Koh,
  • Luke R. Bonser,
  • Walter L. Eckalbar,
  • Ofer Yizhar-Barnea,
  • Jiangshan Shen,
  • Xiaoning Zeng,
  • Kirsten L. Hargett,
  • Dingyuan I. Sun,
  • Lorna T. Zlock,
  • Walter E. Finkbeiner,
  • Nadav Ahituv,
  • David J. Erle

Journal volume & issue
Vol. 3, no. 1
p. 100229

Abstract

Read online

Summary: Epithelial responses to the cytokine interleukin-13 (IL-13) cause airway obstruction in asthma. Here we utilized multiple genomic techniques to identify IL-13-responsive regulatory elements in bronchial epithelial cells and used these data to develop a CRISPR interference (CRISPRi)-based therapeutic approach to downregulate airway obstruction-inducing genes in a cell type- and IL-13-specific manner. Using single-cell RNA sequencing (scRNA-seq) and acetylated lysine 27 on histone 3 (H3K27ac) chromatin immunoprecipitation sequencing (ChIP-seq) in primary human bronchial epithelial cells, we identified IL-13-responsive genes and regulatory elements. These sequences were functionally validated and optimized via massively parallel reporter assays (MPRAs) for IL-13-inducible activity. The top secretory cell-selective sequence from the MPRA, a novel, distal enhancer of the sterile alpha motif pointed domain containing E-26 transformation-specific transcription factor (SPDEF) gene, was utilized to drive CRISPRi and knock down SPDEF or mucin 5AC (MUC5AC), both involved in pathologic mucus production in asthma. Our work provides a catalog of cell type-specific genes and regulatory elements involved in IL-13 bronchial epithelial response and showcases their use for therapeutic purposes.

Keywords